WuXi AppTec AI/Report
Shanghai, China; Cambridge, Massachusetts, USA; and Reykjavik, Iceland – July 2, 2018 – WuXi Nextcode, a global leader in precision medicine and an integrated platform for genomic R&D applications and big data enablement, announced at the 2018 TechCrunch Hangzhou SummitLifeCODE.ai: A Big Health Data Bank Based on Blockchain Technologyand simultaneously launch the user-side APP on the Apple App Store and Android platforms—Laiyin TribeLifeCODE.ai Data Bank innovatively applies blockchain technology to address the legality and validity of big health data collection, protect user privacy, and create value in data exchange, thereby truly realizing the property rights and assetization of big health data.
A Leading Personal Genomics Service Company in ChinaDr. Gang Chen, Chief Technology Officer of WeGene, Integrated Solutions Provider for Precision MedicineDr. Shi Yaozhou, Chief Operating Officer of SinoTech, and the formerProfessor Duan Tao, President of Shanghai First Maternity and Infant Hospital and Founder of Chuntian Medical Management, as representatives of the first batch of corporate partners, jointly witnessed the launch of LifeCODE.ai.
“Each individual’s health data is a personal asset. WuXi Nextcode’s platform is consistently dedicated to providing superior technological and capability support for the pharmaceutical and broader health industries.”Mr. Yan Gu, Chief Digital Officer of WuXi Nextcodestated, “As a major breakthrough in the application of blockchain technology within the broader health sector, the LifeCODE.ai Data Bank will empower everyone to securely and effectively manage and utilize their personal health data, thereby deriving tangible benefits. We will continue to embrace technological advancements and collaboratively explore the application of frontier technologies such as blockchain to improve human health.”
“LifeCODE.ai’s Big Health Data Bank leverages big data and blockchain technologies to bridge the gap between user health data and research institutions, providing optimal health data matching and analysis.”Mr. Rob Brainin, CEO of WuXi Nextcodestated, “We will also leverage the LifeCODE.ai platform to integrate more health service entities and individual users into the health ecosystem, fully harnessing the exceptional data value generated by the Health Data Bank to drive the development of the broader health industry.”
LifeCODE.ai Health Data Bank simultaneouslyFor Individual and Corporate Users, user data is desensitized, multi-layer encrypted, and stored through members of a specific group and limited third parties (consortium blockchain), ensuring that no data can be queried or read without authorization. Every operation on the data is recorded in an immutable blockchain, allowing users to trace activities at any time and maintain comprehensive control over data security.
About WuXi Nextcode
WuXi NextCODE, a member of the WuXi AppTec Group, was established through the integration of WuXi AppTec’s Genomics Center and Iceland’s NextCODE Health, a leader in precision medicine big data analytics. As a global pioneer in the field of precision medicine, WuXi NextCODE is dedicated to improving human health by leveraging big data from precision medicine. The company offers an integrated, open platform that includes China’s first laboratory to achieve dual accreditation from the U.S. Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists (CAP), as well as the NextCODE precision medicine big data analysis and interpretation system—the only such system globally validated and optimized using whole-genome data from 300,000 individuals. This platform supports both cloud-based and on-premises deployment.
WuXi Nextcode has established branches in Shanghai, China, the United States, and Iceland, providing comprehensive precision medicine solutions to researchers, clinicians, health institutions, and individual consumers worldwide. It empowers global partners to accelerate drug development and diagnostic reagent development, reduce human birth defects, improve rare disease diagnosis, and advance other clinical applications of precision medicine. For more news and information, please visit www.wuxinextcode.com.
